To establish a reliable model for typing HCC patients, we identified five key signature genes (SLC7A11, SLC2A1, ADAM9, ITGAV, and PFKP) that distinguished between the C1 and C2 subgroups. The gene discussed is PFKP; the disease is hepatocellular carcinoma.